GE HealthCare Technologies Inc. (GEHC)
(Delayed Data from NSDQ)
$84.82 USD
+0.74 (0.88%)
Updated Aug 30, 2024 04:00 PM ET
After-Market: $84.90 +0.08 (0.09%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth D Momentum C VGM
GE HealthCare Technologies (GEHC) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$95.13 | $110.00 | $84.00 | 13.14% |
Price Target
Based on short-term price targets offered by 16 analysts, the average price target for GE HealthCare Technologies comes to $95.13. The forecasts range from a low of $84.00 to a high of $110.00. The average price target represents an increase of 13.14% from the last closing price of $84.08.
Analyst Price Targets (16)
Broker Rating
GE HealthCare Technologies currently has an average brokerage recommendation (ABR) of 1.78 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 18 brokerage firms. The current ABR compares to an ABR of 1.88 a month ago based on 16 recommendations.
Of the 18 recommendations deriving the current ABR, 11 are Strong Buy, representing 61.11% of all recommendations. A month ago, Strong Buy represented 56.25%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 11 | 11 | 9 | 8 | 8 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 7 | 7 | 7 | 7 | 7 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.78 | 1.78 | 1.88 | 1.93 | 1.93 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
8/6/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
8/1/2024 | Atlantic Equities | Ed Ridley-Day | Not Available | Strong Buy |
8/1/2024 | Wells Fargo Securities | Lawrence H Biegelsen | Strong Buy | Strong Buy |
7/31/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
7/31/2024 | Not Identified | Not Identified | Hold | Hold |
7/17/2024 | Exane BNP Paribas | Navann Ty | Not Available | Strong Buy |
7/2/2024 | UBS | Graham Doyle | Hold | Hold |
5/30/2024 | Goldman Sachs | David H Roman | Not Available | Hold |
5/21/2024 | Piper Sandler | Jason Bednar | Strong Buy | Strong Buy |
4/30/2024 | Not Identified | Not Identified | Hold | Hold |
4/11/2024 | Mizuho SecuritiesUSA | Anthony Petrone | Strong Buy | Strong Buy |
4/4/2024 | Evercore Partners | Vijay Kumar | Not Available | Strong Buy |
4/3/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
4/1/2024 | Argus Research Corp. | David A Toung | Not Available | Strong Buy |
2/15/2024 | Not Identified | Not Identified | Not Available | Strong Buy |
1/7/2024 | BTIG | Ryan Zimmerman | Hold | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.78 |
ABR (Last week) | 1.78 |
# of Recs in ABR | 18 |
Average Target Price | $95.13 |
LT Growth Rate | 6.30% |
Industry | Medical Info Systems |
Industry Rank by ABR | 69 of 253 |
Current Quarter EPS Est: | 1.06 |